Ayman Arafa

Background

About Ayman Arafa

Responsible for promoting of-Concor Amlo 5/5 (Bisoprolol Amlodipine Brand) launching-Concor Range as an anti hypertensive (Bisoprolol Brand)-Glucovance (Metformin/Glibenclamide brand) as an oral aniti-diabetic agent. -Glucophage XR (Metformin Brand)-Adancor (Nicorandil brand) as an anti anginal agent in Behera territory. - Winner of Merck innovation award. - Merck Sales Academy Holder. -*History of HCPs specialities i worked with-Cardiology-Internal medicine-ICU-CCU-Psychiatry-Neuro surgery-Neurology-ENT. -*History of products promotion at Apex Pharma -Erastapex Trio as Olmesartan/AML/HCT an Antihypertensive Product (successful launch, a market leader and total line best achiever)-ZalhinApex as Memantine for treatment of dementia and autism (successful launch)-Quitapex XR as quietiapine (successful relaunch) for treatment of bipolar and schizophrenia-Decancit SR for treatment of sinusitis (successful relaunch)-Stroka clopidogrel for treatment of ischemic events-Levepex as levitracetam for treatment of epilepsy-Examide 5mg as Torsemide as a diuretic-Eraloner as eplerenone for treatment of heart failure (successful relaunching)-Atomox-Apex as atomoxetine for treatment of ADHD-Donhimer as donpezil for treatment dementia-Erastapex plus as Olmesartan/HCT for treatment of hypertension-Quitapex 25 mg as quetiapine for sedation.